# SCICLONE PHARMACEUTICALS INC

SCICLONE PHARMACEUTICALS INC is a company headquartered in Foster City, CA, United States.

## Company overview

- **Legal name:** SCICLONE PHARMACEUTICALS INC
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Foster City, CA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0000880771

## About

SCICLONE PHARMACEUTICALS INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0000880771, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2017-03-09, it reported annual revenue of USD 160,096,000; net income of USD 30,729,000; total assets of USD 241,898,000 for the fiscal period ended 2016-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2016 (period ended 2016-12-31)

- **Revenue:** $160.1M (USD 160,096,000)
- **Net income:** $30.7M (USD 30,729,000)
- **Total assets:** $241.9M (USD 241,898,000)
- **Cash and equivalents:** $134.4M (USD 134,395,000)

### FY2015 (period ended 2015-12-31)

- **Revenue:** $157.3M (USD 157,257,000)
- **Net income:** $29.5M (USD 29,463,000)
- **Total assets:** $216.6M (USD 216,619,000)
- **Cash and equivalents:** $101.4M (USD 101,403,000)

### FY2014 (period ended 2014-12-31)

- **Revenue:** $134.8M (USD 134,790,000)
- **Net income:** $25.2M (USD 25,208,000)
- **Total assets:** $181.8M (USD 181,831,000)
- **Cash and equivalents:** $86.2M (USD 86,228,000)

### FY2013 (period ended 2013-12-31)

- **Revenue:** $127.1M (USD 127,058,000)
- **Net income:** $11.0M (USD 10,964,000)
- **Total assets:** $180.2M (USD 180,227,000)
- **Cash and equivalents:** $85.8M (USD 85,803,000)
- **Operating cash flow:** $9.5M (USD 9,502,000)
- **Later filings:** Total assets: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2017-10-13 — period 2017-10-13 — FORM 8-K
- Form 8-K — filed 2017-09-27 — period 2017-09-27 — 8-K
- Form 8-K — filed 2017-08-10 — period 2017-08-10 — FORM 8-K
- Form 10-Q — filed 2017-08-09 — period 2017-06-30 — 10-Q
- Form 8-K — filed 2017-08-09 — period 2017-08-09 — 8-K
- Form SC 13D — filed 2017-07-27 — SCICLONE PHARMACEUTICALS, INC.
- Form 8-K — filed 2017-06-23 — period 2017-06-22 — 8-K
- Form 8-K — filed 2017-06-09 — period 2017-06-08 — FORM 8-K
- Form 8-K — filed 2017-06-08 — period 2017-06-07 — 8-K
- Form 10-Q — filed 2017-05-10 — period 2017-03-31 — 10-Q
- Form 8-K — filed 2017-05-10 — period 2017-05-10 — 8-K
- Form 8-K — filed 2017-05-09 — period 2017-05-04 — 8-K

---

Updated: 2026-10-23T20:12:17Z

Canonical page: https://altss.com/profile/sciclone-pharmaceuticals-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology